Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis.

Int Arch Allergy Immunol · 2025 · PMC12169803 · PMID 39647474

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Here, 0.15% AZE showed significant ( p = 0.005) improvement in rTNSS compared to placebo from day 2 to 28, whereas the improvement in 0.10% AZE did not reach statistical significance during the first week of treatment.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.